ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 218 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q3 2021. The put-call ratio across all filers is 0.95 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $341,740 | -32.2% | 50,930 | -10.8% | 0.00% | -33.3% |
| Q1 2023 | $504,317 | -18.4% | 57,114 | -29.4% | 0.00% | -25.0% |
| Q4 2022 | $617,794 | -25.1% | 80,863 | -30.2% | 0.00% | -42.9% |
| Q3 2022 | $825,000 | +36.6% | 115,826 | +684.0% | 0.01% | +75.0% |
| Q2 2021 | $604,000 | +45.2% | 14,773 | +42.9% | 0.00% | +33.3% |
| Q1 2021 | $416,000 | -82.7% | 10,338 | -74.5% | 0.00% | -85.7% |
| Q4 2020 | $2,399,000 | +19.0% | 40,565 | -2.2% | 0.02% | 0.0% |
| Q3 2020 | $2,016,000 | +62.2% | 41,462 | +61.3% | 0.02% | +61.5% |
| Q2 2020 | $1,243,000 | – | 25,698 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 3,030,434 | $23,152,516 | 15.55% |
| BERYLSON CAPITAL PARTNERS, LLC | 289,726 | $2,213,507 | 6.45% |
| Matrix Capital Management Company, LP | 11,572,590 | $88,414,588 | 1.69% |
| Pier Capital, LLC | 1,012,401 | $7,734,744 | 1.27% |
| VIKING GLOBAL INVESTORS LP | 29,993,708 | $229,151,929 | 1.15% |
| Eagle Health Investments LP | 607,860 | $4,644,050 | 1.07% |
| Triatomic Management LP | 130,805 | $999,350 | 0.84% |
| Aristotle Atlantic Partners, LLC | 1,880,567 | $14,367,532 | 0.80% |
| Senator Investment Group LP | 1,000,000 | $7,640,000 | 0.69% |
| ARK Investment Management | 9,201,245 | $70,297,512 | 0.61% |